This site is intended for healthcare professionals only
LoginRegister
Alembic Pharma appoints Jigr Shah as Head - Business FinanceAlembic Pharma appoints Jigr Shah as Head - Business Finance
DTAB Agrees to Prohibit 16 FDCs Identified as IrrationalDTAB Agrees to Prohibit 16 FDCs Identified as Irrational
CDSCO Panel Demands Structured Phase IV Protocol for Ademetionine in Liver Disease SubtypesCDSCO Panel Demands Structured Phase IV Protocol for Ademetionine in Liver Disease Subtypes
Trademark Win for Mankind: HC Rejects FLORASIS Over Similarity with FLORAMankind Pharma hit with over Rs 341 crore additional tax demand from IT authority
GSK to buy efimosfermin to treat, prevent progression of steatotic liver diseaseGSK to acquire liver disease drug Efimosfermin for up to USD 2 billion
Indoco Remedies arm launches heart attack drug Ticagrelor filmcoated in UKUSFDA clears Alembic Pharma cardio drug Rivaroxaban, launch expected in next year
USFDA issues EIR for Zydus Lifesciences Ambernath facilityUSFDA issues EIR for Zydus Lifesciences Ambernath facility
Marksans Pharma arm gets marketing authorization in UK for Metformin Hydrochloride 500 mg/ 5ml Oral SolutionAfter Baclofen, now Gabapentin: Marksans Pharma arm bags another UK MHRA green light
Merck, Daiichi Sankyo withdraw US appication for patritumab deruxtecan for advanced or metastatic EGFR-mutated non-small cell lung cancerMerck scores USFDA OK for Welireg for 12 years and older with pheochromocytoma or paraganglioma
AbbVie Emrelis gets USFDA accelerated approval for a type of lung cancerAbbVie Emrelis gets USFDA accelerated approval for a type of lung cancer
USFDA concludes inspection at Shilpa Medicare Raichur unitShilpa Pharma Lifesciences Unit 1 gets EIR from USFDA
DCGI Told to Act Against Unapproved Antibiotic FDCsDCGI Told to Act Against Unapproved Antibiotic FDCs
X